{{Rsnum
|rsid=17530068
|Chromosome=6
|position=81483392
|Orientation=plus
|GMAF=0.1983
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 31.2 | 62.5
| HCB | 5.9 | 37.0 | 57.0
| JPT | 5.3 | 33.6 | 61.1
| YRI | 0.0 | 4.1 | 95.9
| ASW | 1.8 | 14.0 | 84.2
| CHB | 5.9 | 37.0 | 57.0
| CHD | 1.8 | 37.6 | 60.6
| GIH | 1.0 | 29.7 | 69.3
| LWK | 0.9 | 7.3 | 91.8
| MEX | 6.9 | 36.2 | 56.9
| MKK | 0.6 | 16.7 | 82.7
| TSI | 2.0 | 39.6 | 58.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22976474
|Title=A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23535733
  |Trait=Breast cancer
  |Title=Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
  |RiskAllele=C
  |Pval=3E-6
  |OR=1.09
  |ORtxt=[1.05-1.13]
  |OA=1
}}

{{PMID Auto GWAS
  |PMID=23535729
  |Trait=Breast cancer
  |Title=Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
  |RiskAllele=G
  |Pval=8E-9
  |OR=1.05
  |ORtxt=[1.03-1.08]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}